There is no way to completely get rid of herpes. Once herpes simplex virus (HSV-1 or HSV-2) infects you, it stays in your body permanently. But that headline fact doesn’t tell the whole story. With the right treatment approach, many people reduce outbreaks to near zero, cut transmission risk significantly, and go long stretches without symptoms. The real question isn’t how to eliminate the virus. It’s how to manage it so effectively that it barely affects your life.
Why Herpes Can’t Be Cured Yet
After an initial infection, herpes retreats into sensory nerve cells near the base of the spine (for genital herpes) or near the ear (for oral herpes). Inside those neurons, the virus goes dormant. It wraps its DNA into compact circular loops, silences nearly all of its genes, and hides from the immune system. Your body can’t detect it, and your immune cells can’t reach it.
Every antiviral medication currently available works by blocking the virus from copying itself. That’s useful during an active outbreak, when the virus is replicating in skin and mucous membrane cells. But those drugs have zero effect on the dormant viral DNA sitting quietly in your nerve cells. It’s like having a security system that only catches burglars in the act but can’t find the ones hiding in the walls. Until medicine finds a way to reach and destroy that hidden DNA, herpes remains a lifelong infection.
Antiviral Medication for Outbreaks
Three prescription antivirals form the backbone of herpes treatment: acyclovir, valacyclovir, and famciclovir. All three work through the same basic mechanism, blocking the virus from replicating. The differences come down to how often you take them and how conveniently they fit into your routine.
For a first outbreak, which is typically the most painful and longest-lasting, treatment runs 7 to 10 days and can be extended if sores haven’t fully healed. Valacyclovir is often preferred because you only take it twice a day, compared to three times daily for acyclovir or famciclovir. Starting medication early, ideally within the first 72 hours of symptoms, shortens healing time and reduces severity.
For recurrent outbreaks, treatment courses are shorter. Some regimens last as little as one to two days. The key is starting at the very first sign of an outbreak, during the tingling or burning phase before sores appear. If you wait until blisters have already formed, the medication still helps but won’t shorten the episode as dramatically. Many people keep a prescription on hand so they can begin treatment immediately when they feel prodromal symptoms.
Daily Suppressive Therapy
If you experience frequent outbreaks (roughly six or more per year), daily antiviral medication can change your experience with herpes dramatically. Suppressive therapy means taking a low dose of an antiviral every single day, whether or not you have symptoms. The most common regimen is valacyclovir once daily, though acyclovir twice daily and famciclovir twice daily are equally effective options.
Daily therapy reduces outbreak frequency by 70% to 80% in most people. Many go from multiple outbreaks per year to one or none. It also reduces asymptomatic viral shedding, the periods when the virus is present on the skin surface without causing visible sores. This matters because shedding is one of the main ways herpes spreads to partners. Combined with condom use, daily suppressive therapy substantially lowers the chance of passing the virus to a sexual partner.
For people with HSV-1 genital herpes rather than HSV-2, recurrences tend to be less frequent naturally. Suppressive therapy is generally reserved for those who still experience frequent outbreaks rather than prescribed as a default.
Over-the-Counter Options for Cold Sores
For oral herpes (cold sores), docosanol cream, sold as Abreva, is the only FDA-approved nonprescription antiviral. It works differently from prescription antivirals. Instead of targeting viral replication directly, it helps block the virus from entering healthy skin cells. Clinical trials demonstrated that it modestly shortens healing time when applied at the first sign of a cold sore, typically by about half a day to a full day compared to no treatment.
Docosanol won’t dramatically alter the course of an outbreak the way prescription antivirals can, but it’s a reasonable first-line option if you get occasional cold sores and want something accessible without a prescription. Other OTC products like lip balms with numbing agents or anti-inflammatory ingredients can help with pain and discomfort but don’t have antiviral effects.
Triggers That Cause Outbreaks
The dormant virus doesn’t reactivate randomly. Specific triggers weaken local immune defenses and give the virus a window to travel back down the nerve to the skin surface. Identifying and managing your personal triggers is one of the most practical things you can do to reduce outbreaks.
Stress is one of the most well-documented triggers. When you’re under psychological stress, your body releases cortisol and epinephrine, both of which suppress key parts of your immune response. Cortisol dials down the production of inflammatory signals your body needs to keep the virus contained. Epinephrine specifically weakens the ability of certain immune cells to destroy virus-infected cells. Chronic stress is worse than acute stress because it keeps these suppressive hormones elevated over longer periods.
Sun exposure is another major trigger, particularly for oral herpes. Ultraviolet radiation suppresses the skin’s local immune response, reducing its ability to present viral proteins to immune cells and mount a defense. It also triggers inflammation that can further disrupt the balance keeping the virus dormant. Wearing SPF 30+ lip balm and limiting prolonged sun exposure on the face can meaningfully reduce cold sore recurrences.
Other common triggers include:
- Fever or illness, which diverts immune resources away from keeping the virus suppressed
- Fatigue and sleep deprivation, which weaken overall immune function
- Hormonal changes, particularly around menstruation
- Local trauma to the affected area, including dental procedures for oral herpes or friction during sex for genital herpes
- Poor nutrition, especially dietary deficiencies that impair immune health
Tracking your outbreaks alongside potential triggers for a few months can help you identify patterns specific to your body. Some people find that managing stress through sleep, exercise, and mental health support reduces their outbreaks as effectively as any single intervention.
Reducing Transmission to Partners
Even without a cure, you can reduce the risk of passing herpes to a partner through a combination of strategies. Daily suppressive antiviral therapy reduces viral shedding. Consistent condom use provides a physical barrier, though it doesn’t cover all potentially affected skin. Avoiding sexual contact during active outbreaks and during prodromal symptoms (tingling, itching, or burning before sores appear) eliminates the highest-risk periods.
Disclosure to partners matters not just ethically but practically. When both people understand the risks and signs, they can make informed decisions together about timing, barrier use, and whether suppressive therapy makes sense. Many couples where one partner has herpes and the other doesn’t go years without transmission by using these combined approaches.
Where Research Stands on a Cure
The reason herpes can’t be cured today is that no approved drug can reach or destroy dormant viral DNA inside nerve cells. But that specific problem is now the focus of active research using gene-editing technology.
CRISPR-based approaches have shown promising early results. Researchers have designed gene-editing tools that specifically target and cut the viral DNA responsible for HSV-1 infection. In lab-grown brain tissue models using human stem cells, these tools significantly reduced the virus’s ability to reactivate from its dormant state. The approach essentially goes after the hidden viral DNA that current antivirals can’t touch.
On the vaccine front, at least one Phase 1 clinical trial is testing a preventive vaccine designed to stop genital herpes infection before it happens. This trial, studying both safety and immune response in healthy volunteers and people with recurrent genital herpes, has an estimated completion date in late 2026. A preventive vaccine wouldn’t help people already infected, but a successful one could eventually lead to therapeutic versions designed to boost the immune response in people who already carry the virus.
These approaches are still years away from being available as treatments. Gene editing for herpes has not yet been tested in humans, and vaccines must pass through multiple phases of trials before approval. But the scientific path to eliminating latent herpes from the body is more clearly defined now than at any point in the past.